Detalles de la búsqueda
1.
Integrated Analysis of the RASH Study with the Use of the "Burden of Therapy" (BOTh®TM) Methodology-A Novel Tool for Assessing Adverse Events in Metastatic Pancreatic Cancer.
Curr Oncol
; 30(6): 5828-5834, 2023 06 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37366919
2.
Response and Disease Dynamics in Untreated Metastatic Colorectal Cancer With Bevacizumab-Based Sequential vs. Combination Chemotherapy-Analysis of the Phase 3 XELAVIRI Trial.
Front Oncol
; 12: 751453, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35251955
3.
A randomized, phase III trial of capecitabine plus bevacizumab (Cape-Bev) versus capecitabine plus irinotecan plus bevacizumab (CAPIRI-Bev) in first-line treatment of metastatic colorectal cancer: the AIO KRK 0110 trial/ML22011 trial.
BMC Cancer
; 11: 367, 2011 Aug 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-21861888
4.
Gender-dependent survival benefit from first-line irinotecan in metastatic colorectal cancer. Subgroup analysis of a phase III trial (XELAVIRI-study, AIO-KRK-0110).
Eur J Cancer
; 147: 128-139, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33647548
5.
Impact of age on efficacy and early mortality of initial sequential treatment versus upfront combination chemotherapy in patients with metastatic colorectal cancer: a subgroup analysis of a phase III trial (AIO KRK0110, XELAVIRI study).
Eur J Cancer
; 137: 81-92, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32750502
6.
Sequential Versus Combination Therapy of Metastatic Colorectal Cancer Using Fluoropyrimidines, Irinotecan, and Bevacizumab: A Randomized, Controlled Study-XELAVIRI (AIO KRK0110).
J Clin Oncol
; 37(1): 22-32, 2019 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30388045
7.
Elimination of imatinib mesylate and its metabolite N-desmethyl-imatinib.
J Clin Oncol
; 23(16): 3855-6; author reply 3857-8, 2005 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15923584
8.
CNS blast crisis of chronic myelogenous leukemia in a patient with a major cytogenetic response in bone marrow associated with low levels of imatinib mesylate and its N-desmethylated metabolite in cerebral spinal fluid.
Ann Hematol
; 83(6): 401-2, 2004 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-14673623
Resultados
1 -
8
de 8
1
Próxima >
>>